MASH has long been a challenging and progressive liver disease, characterized by fat build-up and inflammation that, if left ...

“These data demonstrating patients with compensated MASH cirrhosis achieved marked ... suggests many patients are moving into lower risk categories for liver-related events.” ...

This marks a significant milestone for HistoIndex as the company enters clinical care for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). "I am excited to see how our core ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...